No Benefit From Macitentan Seen in Systemic SclerosisNo Benefit From Macitentan Seen in Systemic Sclerosis

No differences in reduction of new digital ulcers occurred among groups receiving 3 mg macitentan, 10 mg macitentan, or placebo in two international, multicenter trials. Medscape Medical News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Rheumatology News Source Type: news